Alaunos Therapeutics
NASDAQ: TCRT
Healthcare
Biotechnology
Rank
#43228
Market Cap
4.05 M
Volume
64,146
Price
2.53
Change (%)
12.95%
Country or region
United States
United States
Alaunos Therapeutics's latest marketcap:
4.05 M
As of May 4, 2025, Alaunos Therapeutics's market capitalization has reached $4.05 M. According to our data, Alaunos Therapeutics is the 43228th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.05 M |
| Revenue (ttm) | 10,000 |
| Net Income (ttm) | -4,679,000 |
| Shares Out | 1.60 M |
| EPS (ttm) | -2.92 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 14, 2025 |
Market Cap Chart
Data Updated: May 4, 2025
Alaunos Therapeutics's yearly market capitalization.
Alaunos Therapeutics has seen its market value drop from $91.10 M to $4.10 M since 2006, representing a total decrease of 95.50% and an annual compound decline rate (CAGR) of 15.56%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 2, 2025 | $4.10 M | 32.26% |
| December 31, 2024 | $3.10 M | -81.76% |
| December 29, 2023 | $17 M | -87.88% |
| December 30, 2022 | $140.30 M | -40.45% |
| December 31, 2021 | $235.60 M | -56.37% |
| December 31, 2020 | $540 M | -36.81% |
| December 31, 2019 | $854.50 M | 220.88% |
| December 31, 2018 | $266.30 M | -54.69% |
| December 29, 2017 | $587.70 M | -16.61% |
| December 30, 2016 | $704.80 M | -35.2% |
| December 31, 2015 | $1.09 B | 108.89% |
| December 31, 2014 | $520.70 M | 43.36% |
| December 31, 2013 | $363.20 M | 9.66% |
| December 31, 2012 | $331.20 M | 9.71% |
| December 30, 2011 | $301.90 M | 33.41% |
| December 31, 2010 | $226.30 M | 198.94% |
| December 31, 2009 | $75.70 M | 510.48% |
| December 31, 2008 | $12.40 M | -83.49% |
| December 31, 2007 | $75.10 M | -17.56% |
| December 29, 2006 | $91.10 M |
Company Profile
Frequently Asked Questions
As of May 4, 2025, Alaunos Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $4.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Alaunos Therapeutics global market capitalization ranking is approximately 43228 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 1998 |
| IPO Date | n/a |
| Employees | 1 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |